Matthews GV - Search Results

1

Reinfection incidence and risk among people treated for recent hepatitis C virus infection.

Martinello M, Carson JM, Van Der Valk M, Rockstroh JK, Ingiliz P, Hellard M, Nelson M, Lutz T, Bhagani S, Kim AY, Hull M, Cordes C, Moon J, Feld JJ, Gane E, Rauch A, Bruneau J, Tu E, Applegate T, Grebely J, Dore GJ, Matthews GV; React Study Group. Martinello M, et al. Among authors: matthews gv. AIDS. 2023 Oct 1;37(12):1883-1890. doi: 10.1097/QAD.0000000000003651. Epub 2023 Jul 17. AIDS. 2023. PMID: 37467042

2

Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy.

Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG. Matthews GV, et al. Blood. 2000 Oct 15;96(8):2730-4. Blood. 2000. PMID: 11023505 Free article.

3

The management of chronic hepatitis B infection.

Matthews GV, Nelson MR. Matthews GV, et al. Int J STD AIDS. 2001 Jun;12(6):353-7. doi: 10.1258/0956462011923273. Int J STD AIDS. 2001. PMID: 11368814 Review.

4

Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.

Matthews GV, Pillay D, Cane P, Ratcliffe D, Gazzard B, Nelson M. Matthews GV, et al. Clin Infect Dis. 2001 Dec 15;33(12):2049-54. doi: 10.1086/322655. Epub 2001 Nov 5. Clin Infect Dis. 2001. PMID: 11698987

5

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

Matthews GV, Sabin CA, Mandalia S, Lampe F, Phillips AN, Nelson MR, Bower M, Johnson MA, Gazzard BG. Matthews GV, et al. AIDS. 2002 Jan 4;16(1):53-61. doi: 10.1097/00002030-200201040-00008. AIDS. 2002. PMID: 11741163 Clinical Trial.

6

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.

Nelson M, Portsmouth S, Stebbing J, Atkins M, Barr A, Matthews G, Pillay D, Fisher M, Bower M, Gazzard B. Nelson M, et al. AIDS. 2003 Jan 3;17(1):F7-10. doi: 10.1097/00002030-200301030-00002. AIDS. 2003. PMID: 12478090 Clinical Trial.

7

Non-nucleoside reverse transcriptase inhibitors--an overview.

Bell C, Matthews GV, Nelson MR. Bell C, et al. Among authors: matthews gv. Int J STD AIDS. 2003 Feb;14(2):71-7. doi: 10.1258/095646203321156827. Int J STD AIDS. 2003. PMID: 12662384 Review. No abstract available.

8

BHIVA guidelines: coinfection with HIV and chronic hepatitis C virus.

Nelson MR, Matthews G, Brook MG, Main J; British HIV Association. Nelson MR, et al. HIV Med. 2003 Oct;4 Suppl 1:52-62. doi: 10.1046/j.1468-1293.4.s1.2.x. HIV Med. 2003. PMID: 14511248 Free article. No abstract available.

9

Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.

Matthews G, Dore G. Matthews G, et al. AIDS. 2003 Dec 5;17(18):2675-6. doi: 10.1097/01.aids.0000104338.15729.9a. AIDS. 2003. PMID: 14685063 No abstract available.

10

Treatment for hepatitis C virus infection among current injection drug users in Australia.

Matthews G, Kronborg IJ, Dore GJ. Matthews G, et al. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S325-9. doi: 10.1086/427448. Clin Infect Dis. 2005. PMID: 15768342 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page